PerkinElmer Incorporated

Wikipedia 🌐 PerkinElmer 

People..

ASSOCIATIONS


Saved Wikipedia (July 18, 2022) for "PerkinElmer"

Source : [HK00AE][GDrive

PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets.

PerkinElmer is part of the S&P 500 Index and operates in 190 countries.

History

Founding

Richard Perkin was attending the Pratt Institute in Brooklyn to study chemical engineering, but left after a year to try his hand on Wall Street. Still interested in the sciences, he gave public lectures on various topics. Charles Elmer ran a firm that supplied court reporters and was nearing retirement when he attended one of Perkin's lectures on astronomy being held at the Brooklyn Institute of Arts and Sciences.[2]

The two struck up a friendship over their shared interest in astronomy, and eventually came up with the idea of starting a firm to produce precision optics. Perkin raised US$15,000 from his relatives, while Elmer added US$5,000, and the firm was initially set up as a partnership on 19 April 1937. Initially, they worked from a small office in Manhattan, but soon opened a production facility in Jersey City. They incorporated the growing firm on 13 December 1939. A further move to Glenbrook in Connecticut in 1941 was quickly followed by another move to Norwalk, Connecticut, where the company remained until 2000.[2] The opening of World War II led to significant expansion as the company produces optics for range finders, bombsights, and reconnaissance systems. This work led to the U.S. Navy awarding them the first "E" for Excellence award in 1942.[2]

Perkin-Elmer retained a strong presence in the military field through the 1960s and at the same time was significantly involved with OAO-3 a 36-inch Ultra Violet Space Telescope, Skylab and their major contribution to the Apollo program was the CO2 sensor that saved the astronauts during the Apollo 13 failure. They were a primary supplier of the optical systems used in many reconnaissance platforms, first in aircraft and high-altitude balloons, and then in reconnaissance satellites. A significant advance was 1955's Transverse Panoramic Camera, which took images on 12 by 14 ft (3.7 by 4.3 m) wide frames that provided single-frame images from horizon to horizon from an aircraft flying at 40,000 ft altitude. Such systems remained a major part of the company's income, capped by the installation of laser retroreflectors on the Moon as part of the Apollo 11 mission.[2]

Elmer died at age 83 in 1954, and the company began trading shares over the counter. The company was listed on the New York Stock Exchange on 13 December 1960. Perkin remained as president and CEO until June 1961, when Robert Lewis, previously of Argus Camera and [] Sylvania Electric Products, took over these roles. Perkin remained the chairman of the board until his death in 1969.[2]

Semiconductor manufacturing

In 1967, the U.S. Air Force asked Perkin-Elmer to produce an all-optical "masking" system for semiconductor fabrication. Previous systems used a pattern, the "mask", which was pressed onto the surface of the silicon wafer as part of the photolithography process. Small bits of dirt or photoresist would stick the mask and ruin the patterning for subsequent chips, and it was not uncommon for the vast majority of the chips from a given wafer to malfunction. The Air Force, who by the late 1960s was highly reliant on integrated circuits, desired a more reliable system.[3]

Perkin-Elmer responded with the Microprojector, which was essentially a large photocopier system. The mask was placed in a holder and never touched the surface of the chip. Instead, the image was projected onto the surface. Making this work required a complex 16-element lens system that focussed a single frequency of light onto the mask. The remainder of the light from the 1,000 watt mercury-vapor lamp was filtered out.[3]

Harold Hemstreet was convinced it would be possible to simplify the concept, and Abe Offner began the development of a system using mirrors instead of lenses, which did not suffer from the multispectral focussing problems of lenses. The result of this research was the Projection Scanning Aligner, or Micralign, which made chip making an assembly-line task and improved the number of working chips from perhaps 10% to 70% overnight.[3] Chip prices plummeted as a result, with examples like the MOS 6502 selling for about US$20 while the previous generation of designs like the Motorola 6800 sold for around US$250.

The Micralign was so successful that Perkin-Elmer became the largest single vendor in the chip space in three years. In spite of this success, the company was largely a has-been by the 1980s due to their late response to the introduction of the stepping aligner, which allowed a single small mask to be stepped across the wafer, rather than requiring a single large mask covering the entire wafer. The company never regained their lead, and sold the division to The Silicon Valley Group.[3]

Lab equipment

In the early 1990s, partnered with [Cetus Corporation] (and later Hoffmann-La Roche) to pioneer the polymerase chain reaction (PCR) equipment industry. Analytical-instruments business was also operated from 1954 to 2001 in Germany, by the Bodenseewerk Perkin-Elmer GmbH located in Überlingen at Lake Constance, and England (Perkin Elmer Ltd) at Beaconsfield in Buckinghamshire.

Computer Systems Division

Perkin-Elmer was involved in computer manufacture for a time. The Perkin-Elmer Computer Systems Division was formed through the purchase of Interdata, Inc., an independent computer manufacturer, in 1973–1974 for some US$63 million.[4][5] This merger made Perkin-Elmer's annual sales rise to over US$200 million.[5] This was also known as Perkin-Elmer's Data Systems Group.[6] The 32-bit computers were very similar to an IBM System/370, but ran the OS/32MT operating system.

The Wollongong Group provided the commercial version of the Unix port to the Interdata 7/32 hardware, known as Edition 7 Unix. The port was originally done by the University of Wollongong in New South Wales, Australia, and was the first UNIX port to hardware other than the Digital Equipment Corporation PDP family.[7] By 1982, the Wollongong Group Edition 7 Unix and Programmer's Workbench (PWB) were available on models such as the Perkin-Elmer 3210 and 3240 minicomputers. In 1985, the computing division of Perkin-Elmer was spun off as Concurrent Computer Corporation.[8]

1999

Modern PerkinElmer traces its history back to a merger between divisions of what had been two S&P 500 companies, [EG&G Inc.] of Wellesley, Massachusetts and Perkin-Elmer (formerly NYSE: PKN) of Norwalk, Connecticut. On May 28, 1999, the non-government side of EG&G Inc. purchased the Analytical Instruments Division of Perkin-Elmer, its traditional business segment, for US$425 million, also assuming the Perkin-Elmer name and forming the new PerkinElmer company, with new officers and a new board of directors.[9][10] At the time, [EG&G] made products for diverse industries including automotive, medical, aerospace and photography.[10]

The old Perkin-Elmer Board of Directors and Officers remained at that reorganized company under its new name, PE Corporation. It had been the Life Sciences division of Perkin-Elmer, and its two component tracking stock business groups, Celera Genomics (NYSE: CRA) and PE Biosystems (formerly NYSE: PEB), were centrally involved in the highest profile biotechnology events of the decade, the intense race against the Human Genome Project consortium, which then resulted in the genomics segment of the technology bubble. Perkin-Elmer purchased the Boston operations of NEN Life Sciences in 2001.

Recently

In 1992, [Perkin-Elmer Corporation] merged with [Applied Biosystems].  In 1997, [Perkin-Elmer Corporation] merged with [PerSeptive Biosystems]. On July 14, 1999, the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization.[10] In 2006, PerkinElmer sold off the Fluid Sciences division for approximately US$400 million; the aim of the selloff was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the selloff, a number of small businesses were acquired, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell, and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand until the end of year 2007.

PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories, In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. In 2007, it purchased ViaCell, Inc. for US$300 million,[11] which included its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord. In 2003 Perkin Elmer acquired Packard Bioscience Inc from its majority shareholder, Dick McKernen. This acquisition also came with Agincourt Technologies Inc and consolidated Perkin Elmer's position in laboratory robotics, in particular, liquid handling robots which were to prove essential for the high-throughput sequencing needed for the Human Genome Project.

In March 2008, PerkinElmer purchased Pediatrix Screening (formerly Neo Gen Screening), a laboratory located in Bridgeville, Pennsylvania specializing in screening newborns for various inborn errors of metabolism such as phenylketonuria, hypothyroidism, and sickle-cell disease. It renamed the laboratory PerkinElmer Genetics, Inc.[citation needed]

In May 2011, PerkinElmer announced the signature of an agreement to acquire CambridgeSoft, and the successful acquisition of ArtusLabs.[12]

In September 2011, PerkinElmer bought Caliper Life Sciences for US$600 million.[13]

In January 2016, PerkinElmer acquired Swedish firm Vanadis Diagnostics.[14]

In January 2017, the company announced it would acquire the Indian in vitro diagnostic company, Tulip Diagnostics.[15] In May 2017, the company acquired Euroimmun Medical Laboratory Diagnostics for approximately US$1.3 billion.[16]

In 2018, the company acquired Australian biotech company, RHS Ltd., Chinese manufacturer of analytical instruments, Shanghai Spectrum Instruments Co. Ltd., and France-based company Cisbio Bioassays, which specializes in diagnostics and drug discovery solutions.[17][18][19]

In November 2020, PerkinElmer announced it would acquire Horizon Discovery Group for around US$383 million.[20]

In March 2021, PerkinElmer announced that the company has completed its acquisition of Oxford Immunotec Global PLC (Oxford Immunotec).[21] In May of the same year, the business announced it would purchase Nexcelom Bioscience for $260 million[22][23] and Immunodiagnostic Systems Holdings PLC for $155 million.[24] In June the company announced it would acquire SIRION Biotech, a specialist in viral vector gene delivery methods.[25] In July the business announced it would acquire BioLegend for $5.25 billion.[26]

Acquisition history : PerkinElmer acquisitions

Programs

Hubble optics project

Polishing of Hubble's primary mirror begins at Perkin-Elmer corporation, Danbury, Connecticut, May 1979. The engineer pictured is Dr. Martin Yellin, an optical engineer working for Perkin-Elmer on the project.

Perkin-Elmer's Danbury Optical System unit [27] was commissioned to build the optical components of the Hubble Space Telescope. The construction of the main mirror began in 1979 and completed in 1981. The polishing process ran over budget and behind schedule, producing significant friction with NASA. Due to a miscalibrated null corrector, the primary mirror was also found to have a significant spherical aberration after reaching orbit on STS-31. Perkin-Elmer's own calculations and measurements revealed the primary mirror's surface discrepancies, but the company chose to withhold that data from NASA. A NASA investigation heavily criticized Perkin-Elmer for management failings, disregarding written quality guidelines, and ignoring test data that revealed the miscalibration.[28] Corrective optics were installed on the telescope during the first Hubble service and repair mission STS-61. The correction, Corrective Optics Space Telescope Axial Replacement, was applied entirely to the secondary mirror and replaced existing instrumentation; the aberration of the primary mirror remained uncorrected.

The company agreed to pay US$15 million, essentially forgoing its fees in polishing the mirror, to avoid a threatened liability lawsuit under the False Claims Act by the Federal government. Hughes Aircraft, which acquired the Danbury Optical System unit one month after the launch of the telescope, paid US$10 million. The Justice Department asserted that the companies should have known about the flawed testing. Trade group Aerospace Industries Association protested when concerns were raised in the aerospace industry that aerospace companies might be held liable for failed equipment.[27]

KH-9 Hexagon

Perkin-Elmer built the optical systems for the KH-9 Hexagon series of spy satellites at a facility in Danbury, Connecticut.[29]

In the 1970s, an aerial panoramic camera lens was capable of recording the entire state of Pennsylvania in two flyovers, with resolution that enabled one to count the autos on the Pennsylvania Turnpike.[30]

References

External links

EVIDENCE TIMELINE

1983 (April) - Kary Mullis thinks of PCR test while drivijng his car

1984 (spring) - Lederberg discovers Mullus' idea at a Cetus company event 

1985 (Aug) - Cetus dealing with intellectual property issues related to "muteins" ??? 

https://www.newspapers.com/image/438337862/?terms=cetus&match=1 

1986 (Jan 22) - Creation of Perkin-Elmer Cetus Instruments

https://www.newspapers.com/image/372284849/?terms=cetus%20perkin%20elmer&match=1 

1988 (April 10) 

https://www.newspapers.com/image/461369653/?terms=cetus%20perkin%20elmer&match=1

1988 (Jan 19) - Was Cetus developing PCT test with eastman Kodak?

https://www.newspapers.com/image/137290619/?terms=%22PCR%20test%22&match=1 

1988 (June 30)

https://www.newspapers.com/image/773512769/?terms=cetus%20perkin%20elmer&match=1

1988-06-30-the-commercial-appeal-pg-east-11-clip-genes.jpg

1988 (Sep 05) - The Boston Globe : 

29 https://www.newspapers.com/image/439113984/ 

1988-09-05-the-boston-globe-pg-29-clip-dna-test.jpg

31  https://www.newspapers.com/image/439114047/?terms=cetus%20perkin%20elmer&match=1 

1988-09-05-the-boston-globe-pg-31-clip-dna-test.jpg

1991 (Dec 13)

CETUS MERGES WITH CHIRON ??? 

https://www.newspapers.com/image/145941238/?terms=cetus%20perkin%20elmer&match=1

1997 (Aug 26) - NYTimes : "Perkin to Acquire Perseptive in Stock Swap"

By Lawrence M. Fisher   /   Aug. 26, 1997  /  Source : [HN0236][GDrive

ALSO SEE   :   PerSeptive Biosystems   /  Perkin-Elmer Corporation   /  Dr. Noubar Afeyan (born 1962)  /   Tony Lee White (born 1947)  /    Applied Biosystems 

The [Perkin-Elmer Corporation] said yesterday that it had agreed to acquire [PerSeptive Biosystems] Inc., a maker of laboratory kits and instrumentation used by biotechnology companies, in a stock swap valued at $360 million.

Perseptive, based in Framingham, Mass., is a leading producer of equipment used to separate and identify intact proteins, which form the basis of most biotechnology drugs, and has also developed advanced products for the separation and purification of biological molecules in the life science market. [Perkin-Elmer Corporation], through its 1993 acquisition of [Applied Biosystems] Inc., is a leading provider of DNA sequencing and synthesizing equipment to biotechnology companies.

The acquisition will allow [Perkin-Elmer Corporation] to add greater value to gene-based drug discovery than it has had as a tools provider, said Peter Barrett, Perkin-Elmer's vice president for business development. Making the company a player in the emerging field of genomics, rather than just an instrument vendor, has been a key strategy of [Tony Lee White (born 1947)], who joined Perkin-Elmer two years ago as chairman, president and chief executive.

''If you look at the genomics companies, like Human Genome Sciences or Incyte, the value created by these companies is driven by our systems,'' Mr. Barrett said in a telephone interview. ''What we're trying to do here is move to another level of platform delivery, to move closer to the information.''

The deal valued Perseptive at $13 a share. Its shares surged 17 percent, or $1.8125, to $12.4375 in Nasdaq trading. Perkin-Elmer shares rose 62.5 cents, to $78.6875, on the New York Stock Exchange.

Analysts said the deal would strengthen Perkin-Elmer's product line on the biotechnology side, which is growing, and help offset the slowing of its traditional business in chemical analysis tools. Because Perseptive has not yet been profitable, the deal will reduce earnings per share in the near term, but should provide a long-term income boost, they said.

''They're trying to expand their exposure to biotechnology instrumentation,'' said Lawrence W. Borgman, an analyst with Josephthal Lyon & Ross. ''They're very big in DNA synthesis because of Applied Biosystems; with this they add a presence in proteins as well,'' he said. ''The biotech side of the business is growing and has good margins.''

For Perseptive, which expects revenue of $85 million in its fiscal year ending Sept. 30, the deal removed uncertainties about future financing and distribution.

''We felt that under the value proposition presented to us by Perkin-Elmer, our objectives would be better accomplished by the merger,'' [Dr. Noubar Afeyan (born 1962)], Perseptive's chairman and chief executive officer, said in a telephone interview. ''The constraints we've had will be eliminated.''

1998 (Aug 06) - The Baltimore Sun: "Venter, Perkin-Elmer name venture Celera"

Also mentioned : Perkin-Elmer Corporation  ,  Celera Genomics Corporation  ,   Dr. John Craig Venter (born 1946)  

Full newspaper page : [HN0234][GDrive]  /  Clip above : [HN0235][GDrive]

1999 (March 09) - WSJ : "EG&G to Buy Perkin-Elmer Unit For $425 Million, Change Its Name"

https://www.wsj.com/articles/SB920940755343119000?mod=Searchresults_pos17&page=7

1999-03-09-wsj-coim-egg-perkin-elmer-unit-img-1.jpg

WELLESLEY, Mass. -- Signaling a strategic shift, EG&G Inc. said it plans to buy the analytical instruments division of Perkin-Elmer Corp. for $425 million and is considering selling its defense-contracting unit.

Perkin-Elmer, also changing focus, said it will concentrate on genetic instrumentation. With the sale, Perkin-Elmer will change its name to PE Corp., transferring rights to the "Perkin-Elmer" brand name to EG&G. EG&G will pay $275 million in cash and issue Perkin-Elmer a $150 million note, maturing in one year and paying a 5% coupon.

EG&G is seeking to shift from low-margin government work to what it hopes will be more profitable commercial technology. The Perkin-Elmer unit, with annual sales of $569 million, makes instruments that measure uniformity in drugs and medicines and ensure the purity of food and water.

EG&G said the transaction, to close in the second quarter, wouldn't dilute 1999 earnings, excluding acquisition-related charges. Greg Summe, the company's chief executive officer, said the acquisition could add an unspecified amount to earnings in 2000 and 50 cents a share in 2001. Analysts expect the company, with about $1.4 billion in annual sales, to earn $1.57 a share in 1999 and $1.80 in 2000, according to First Call.

EG&G said it hired Goldman, Sachs & Co. to explore "strategic alternatives" for its technical services unit, with expected 1999 sales of $450 million. Mr. Summe said options include selling the division, or taking a partner. The unit provides management, scientific and operations support services to government customers, including the Defense Department and Federal Aviation Administration.